Invus is a private equity firm founded in 1985 and based in New York City. See contact routes.
Invus is a private equity firm founded in 1985 and based in New York City, operating as an evergreen equity investor with over $10 billion under management. The firm sources its capital from a European family group and does not raise outside funds, focusing instead on value creation through majority control positions in companies with transformational strategies and minority investments in high-growth firms. Invus primarily invests in the United States and United Kingdom across diverse sectors including life sciences, enterprise applications, consumer products, software, biotech, and medical devices. While specific check sizes and lead/follow behavior are not publicly detailed, the firm’s latest known investment was a Series B round in Osanni in June 2026. Notable portfolio companies include Osanni, though the firm’s portfolio spans 265 companies overall. Invus distinguishes itself by taking significant long-only, long-term public equity positions in companies it believes have strong fundamentals and management, alongside its private equity activities. The firm maintains offices in New York, Paris, and Hong Kong, reflecting its global investment scope[
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find comparable investors.
Investors like Invus · Full investor directory · Investor access · Company funding database